ArticleThe Journal of physiology2025
Obligatory and accessory respiratory muscle structure, function and control in early and advanced disease in the mdx mouse model of Duchenne muscular dystrophy.
Article in The Journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Inflammaging-associated mitochondrial degeneration occurs in hypoglossal motor neurons prior to tongue muscle.GeroScience · 2026Article
- Neuromuscular and neuromechanical assessments of respiratory performance in the mdx mouse model of Duchenne muscular dystrophy across the natural history of disease.Experimental physiology · 2026Article
- PPMO-based exon skipping therapy improves respiratory function in theMolecular therapy. Nucleic acids · 2026Article
- Stepping up to inspire in muscular dystrophy.The Journal of physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Peak inspiratory pressure-generating capacity is preserved in the mdx mouse model of Duchenne muscular dystrophy in early disease, despite profound diaphragm muscle weakness and reduced electrical activation, revealing adequate compensation by extra-diaphragmatic muscles. Respiratory system compensation is lost as disease progresses, with the emergence of reduced peak inspiratory pressure-generating capacity in advanced disease. We hypothesised that extra-diaphragmatic inspiratory muscles compensate for diaphragm dysfunction in early dystrophic disease, supporting the maintenance of peak respiratory performance in mdx mice. We reasoned that extra-diaphragmatic muscle dysfunction would emerge with progressive disease, leading to the loss of peak inspiratory pressure-generating capacity in advanced dystrophic disease. We measured ventilation, inspiratory pressure, and obligatory (diaphragm, intercostal and parasternal) and accessory (sternomastoid, cleidomastoid, scalene and trapezius) respiratory muscle form, function and EMG activity in early (4 months) and advanced (16 months) dystrophic disease. Despite obligatory and accessory muscle dysfunction, including structural remodelling, weakness and reduced EMG activity, peak inspiratory pressure-generating capacity and ventilation are preserved in early disease. Obligatory and accessory muscle dysfunction progressively declines with advanced disease, with the emergence of reduced peak inspiratory pressure-generating capacity. However, although there was evidence of progressive accessory muscle dysfunction, more profound remodelling was seen in the diaphragm muscle comparing early and advanced dystrophic disease. In conclusion, in early dystrophic disease, peak inspiratory performance is compensated. A progressive decline in diaphragm and extra-diaphragmatic muscles contributes to respiratory system compromise in advanced disease. Further loss of compensation afforded by extra-diaphragmatic muscles probably contributes to end-stage respiratory failure. KEY POINTS: We characterised obligatory and accessory respiratory muscle form, function and control in early and advanced disease in the mdx mouse model of Duchenne muscular dystrophy. Profound diaphragm muscle remodelling, immune cell infiltration, elevated cytokine concentrations and dysfunction present in early disease, but peak inspiratory performance is fully compensated. The burden of breathing is shared across many muscles, revealed as remodelling, elevated cytokine concentrations, weakness and impaired control in several obligatory and accessory muscles. Peak inspiratory performance declines in advanced disease with evidence of progressive remodelling in the diaphragm muscle with extensive fibrosis and further decline in the form, function and control of accessory muscles of breathing. Diaphragm remodelling with profound fibrosis, more so than progressive accessory muscle remodelling (although evident), is the striking phenotype at 16 months of age when the decline in peak inspiratory performance appears. The progressive decline to end-stage disease (∼20-22 months of age in mdx mice) probably relates to continued profound loss of diaphragm contractile function and loss of compensatory support provided by extra-diaphragmatic muscles. Logistically convenient models of rapid, progressive muscular dystrophy are required to facilitate the study of end-stage disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.